Search for: "Abbott Laboratories, Inc."
Results 241 - 260
of 451
Sorted by Relevance
|
Sort by Date
29 Jun 2010, 6:01 pm
Reddy’s Laboratories, Ltd. et al. [read post]
30 Jun 2010, 5:52 am
Reddy's Laboratories, Ltd. et al. [read post]
21 May 2009, 10:03 am
Regardless of whether we elect John McCain or Barack Obama, my hope is that we can get someone who actually knows a thing...Patent SOS: Inequitable Conduct Reform ASAPNot long ago the United States Court of Appeals for the Federal Circuit issued a decision in Abbott Laboratories v. [read post]
2 Dec 2009, 4:31 am
Because other countries just decide to pay less – Pfizer’s patent battle against UniLab (Patent Baristas) Moxifloxacin – Venezuela annuls two of Bayer’s patents relating to Moxifloxacin (IP tango) (IP tango) Plavix (Clopidogrel) – India: Indian company, Cadila, bears the brunt of section 3(d) (Spicy IP) Sanctura (Trospium) – US: Allergan files patent infringement suit against Sandoz in response to Para IV challenge (Patent Docs) Taxotere (Docetaxel) –… [read post]
14 Jul 2010, 6:47 pm
Anika Therapeutics, Inc. [read post]
28 Nov 2008, 12:49 pm
victories in fight for European BRCA patents (Holman's Biotech IP Blog) Europe: European Commission proposes strategy for dealing with rare diseases (Pharmacapsules @ Gowlings) US: Former House Ways and Means Economist claims 7-year data exclusive period is sufficient (Patent Docs) US: Medco predicts follow-on biologics regulatory pathway by 2011 (Patent Docs) US: Even after patent has expired, District Court has jurisdiction to set exclusivity date: In re Omeprazole Patent Litigation… [read post]
19 Sep 2014, 3:00 am
The Eighth Circuit found that the dicta In re Abbott Laboratories, Inc., 698 F.3d 568 (7th Cir. 2012) applied to this case. [read post]
22 Apr 2013, 2:43 pm
Abbott Laboratories Inc. agreed to pay $1.5 billion in order to resolve criminal and civil allegations surrounding the company’s off-label marketing of Depakote. [read post]
9 Sep 2009, 7:14 am
– Dispute between Wyeth and Dexel (The IP Factor) EpiPen (Epinephrine) – US: King Pharmaceuticals, Meridian Medical Technology file patent infringement suit against Teva following Para IV certification (Patent Docs) Seroxat (Paroxetine) – Israel: not even sublime, just ridiculous – Israel PTO decision in Unipharm v SmithKline Beecham (America-Israel Patent Law) Stelara (Ustekinumab, anti-IL-12 antibody) – Centocor seeks review of BPAI decision… [read post]
19 May 2010, 6:15 am
(Patent Docs) US: CAFC affirms claim construction and corresponding summary judgment of non-infringement: Scantibodies Laboratory, Inc. v. [read post]
5 Aug 2014, 9:09 am
Studies Indicate Health Risks from Testosterone Therapy AndroGel is a topical testosterone-replacement medication produced and marketed by Abbott Laboratories and its AbbVie Inc. subsidiary. [read post]
14 Jul 2010, 11:55 am
. * * * * Advanced Magnetic Closures, Inc. v. [read post]
13 Jan 2009, 2:19 pm
Abbott Laboratories, Inc., No. 06-55687 (9th Cir. [read post]
20 Oct 2010, 5:41 am
" The suit, filed against Abbott Laboratories Inc., comes after a September 22, 2010 recall "following two reports from consumers of beetle larvae in the formula. [read post]
20 Oct 2010, 5:41 am
" The suit, filed against Abbott Laboratories Inc., comes after a September 22, 2010 recall "following two reports from consumers of beetle larvae in the formula. [read post]
4 Jun 2008, 8:32 pm
TNF blockers currently approved for pediatric use include etanercept (Enbrel, Immunex Corp, marketed by Amgen and Wyeth Pharmaceuticals), adalimumab (Humira, Abbott Laboratories), and infliximab (Remicade, Centocor, Inc). [read post]
19 Mar 2012, 8:32 am
Abbott Laboratories, Inc., 2012 WL 764199 (E.D.N.Y.) [read post]
3 Sep 2009, 6:44 pm
Abbott Laboratories, 297 F.3d 544 (7th Cir. 2002); United States v. [read post]
2 May 2014, 10:23 am
Despite Auxilium Pharmaceuticals’ opposition, a joint response filed on behalf of other testosterone drug manufactures such as Abb Vie, Inc., Abbott Laboratories, Eli Lilly and Co., Lilly USA, LLC, and Endo Pharmaceuticals, Inc. indicates support for the centralization of all pending testosterone replacement therapy lawsuits before the same judge. [read post]
16 Aug 2018, 6:38 pm
.,551 F.2d 213, 219 (8th Cir. 1997))).(...)We ruled in Abbott Laboratories v. [read post]
